How to manage a 93-year-old woman with moderate multi-infarct dementia, agitation, confusion, and distress, who is on citalopram (selective serotonin reuptake inhibitor) and frequently requests to leave her retirement home facility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Agitation, Confusion, and Distress in a 93-Year-Old Woman with Multi-Infarct Dementia

A comprehensive approach combining non-pharmacological interventions and careful medication management is recommended for this 93-year-old woman with moderate multi-infarct dementia experiencing agitation, confusion, and distress, with citalopram dosage requiring careful evaluation and possible adjustment.

Initial Assessment and Non-Pharmacological Approaches

  • Perform a thorough assessment of potential causes for the patient's agitation, confusion, and distress, including evaluation for pain, discomfort, infections, dehydration, fecal impaction, and adverse medication effects 1
  • Describe and quantify verbal, nonverbal, and physical behavioral symptoms to better understand patterns and triggers 1
  • Assess for environmental, situational, social, and psychological factors that may be contributing to her distress 1
  • Implement an interdisciplinary approach involving the patient's family and retirement home staff to develop individualized care plans 1

Non-Pharmacological Interventions (First-Line)

  • Provide meaningful activities tailored to the patient's past roles, interests, and current abilities 1, 2
  • Increase social engagement through structured activities appropriate for her cognitive level 1
  • Improve communication techniques with the patient:
    • Use calmer tones and simpler single-step commands 1
    • Avoid complex multi-step instructions or open-ended questioning 1
    • Consider light touch to reassure and redirect 1
  • Establish predictable daily routines that promote safety and well-being 1
  • Address loneliness and social isolation through appropriate social support programs 1
  • Consider environmental modifications to create a more homelike atmosphere with familiar objects 1

Medication Management

Current Citalopram Treatment

  • Evaluate the current dose of citalopram, which should not exceed 20 mg/day in patients over 60 years due to risk of QT prolongation 3
  • Monitor for potential adverse effects of citalopram, including:
    • QT interval prolongation (particularly concerning in elderly patients) 3
    • Cognitive worsening (which could exacerbate confusion) 3, 4
    • Serotonin syndrome (especially if combined with other medications) 3
    • Worsening agitation or anxiety 3

Medication Adjustments

  • Consider reducing citalopram to 20 mg daily if currently at a higher dose, as this lower dose may still be effective for agitation while minimizing cardiac and cognitive risks 5, 3
  • SSRIs like citalopram are considered first-line pharmacological treatments for agitation in dementia when medication is necessary 2, 6
  • In the CitAD trial, citalopram showed significant improvement in agitation compared to placebo but with concerns about QT prolongation and cognitive effects at 30 mg daily 4
  • Avoid adding antipsychotics if possible, as they pose significant safety risks including increased mortality in elderly patients with dementia 7
  • Make periodic attempts (every 6 months) to taper or discontinue medication for dementia-related behavioral symptoms 1

Ongoing Monitoring and Follow-up

  • Regularly reassess the effectiveness of both non-pharmacological and pharmacological interventions 1
  • Monitor vital signs, cognitive function, and cardiac status (particularly QTc interval) 3
  • Evaluate for any new medical conditions or medication side effects that could be contributing to behavioral symptoms 1
  • Involve the daughter in care planning and provide education about dementia behaviors not being intentional 1
  • Consider a trial of dose reduction after 3-6 months if symptoms have significantly improved 7

Addressing Specific Concerns

  • For the patient's desire to leave the facility:
    • Validate her feelings rather than contradicting them 1
    • Redirect to meaningful activities that provide purpose and engagement 1
    • Consider whether her requests reflect unmet needs (physical discomfort, boredom, loneliness) 1
    • Provide reassurance and orientation to her current environment 1

Caregiver Support and Education

  • Educate the daughter about the link between dementia and behavioral symptoms 1
  • Emphasize that behaviors are not intentional but manifestations of the disease 1
  • Provide strategies for effective communication and managing difficult situations 1
  • Connect the daughter with support resources to manage caregiver stress 1

Common Pitfalls to Avoid

  • Avoid excessive reliance on medications without addressing underlying causes of distress 1, 2
  • Do not dismiss the patient's expressions of wanting to leave as merely symptoms; they may indicate legitimate unmet needs 1
  • Avoid confrontational approaches or complex explanations that may increase agitation 1
  • Do not overlook the importance of regular medication review and attempts at dose reduction 1
  • Avoid using physical restraints or unnecessary psychotropic medications to manage wandering behaviors 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Agitation in Dementia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Role of citalopram in the treatment of agitation in Alzheimer's disease.

Neurodegenerative disease management, 2014

Research

Antidepressants for agitation and psychosis in dementia.

The Cochrane database of systematic reviews, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.